# Angiodynamics Inc: Form 10-Q/A for the period ended Aug 31, 2012

- Company: [Angiodynamics Inc](/companies/ango.md) (CIK 1275187)
- Form: 10-Q/A
- Filed: 2012-11-09
- Accepted by EDGAR: Nov 9, 2012, 10:38 ET
- Period: 2012-08-31
- Accession: 0001193125-12-462191
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1275187/000119312512462191/d409549d10qa.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1275187/000119312512462191/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2012-08-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2012-06-01 to 2012-08-31 | $83.4m | us-gaap:SalesRevenueNet |
| Cost of revenue | 3 months, 2012-06-01 to 2012-08-31 | $43.9m | us-gaap:CostOfGoodsSold |
| Gross profit | 3 months, 2012-06-01 to 2012-08-31 | $39.5m | us-gaap:GrossProfit |
| Research and development | 3 months, 2012-06-01 to 2012-08-31 | $7.1m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months, 2012-06-01 to 2012-08-31 | $684.0k | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months, 2012-06-01 to 2012-08-31 | $1.3m | us-gaap:InterestExpense |
| Income tax | 3 months, 2012-06-01 to 2012-08-31 | −$433.0k | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2012-06-01 to 2012-08-31 | −$721.0k | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2012-06-01 to 2012-08-31 | −$0.02 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2012-06-01 to 2012-08-31 | −$0.02 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2012-06-01 to 2012-08-31 | 34,704,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months, 2012-06-01 to 2012-08-31 | −$5.6m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months, 2012-06-01 to 2012-08-31 | $968.0k | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | at 2012-08-31 | $18.9m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2012-08-31 | $160.6m | us-gaap:AssetsCurrent |
| Total assets | at 2012-08-31 | $718.4m | us-gaap:Assets |
| Current liabilities | at 2012-08-31 | $52.4m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2012-08-31 | $194.5m | us-gaap:Liabilities |
| Long-term debt | at 2012-08-31 | $140.6m | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | at 2012-08-31 | $7.5m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | at 2012-08-31 | $523.9m | us-gaap:StockholdersEquity |

## Sections

No standard item headings were found in this filing’s main document, so no sections were extracted. Read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/1275187/000119312512462191/d409549d10qa.htm

Filed Nov 9, 2012.
Source: SEC EDGAR, the filing index for accession 0001193125-12-462191. Last ingested by Listed: Nov 4, 2026, 20:24 ET. No prices; not investment advice.
